Gangwon, South Korea

Sungman Park

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Immunemed Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sungman Park. Retrieved from https://idiyas.com/inventor/sungman-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sungman Park in Skin Disease Treatment

Introduction

Sungman Park is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of skin diseases. His innovative approach utilizes humanized antibodies to target specific proteins involved in skin conditions.

Latest Patents

Sungman Park holds a patent for a method of treating skin diseases using a humanized antibody that binds to vimentin. This pharmaceutical composition aims to provide a novel treatment option for patients suffering from various skin ailments. The patent highlights the potential of using targeted therapies to improve patient outcomes.

Career Highlights

Sungman Park is associated with Immunemed Inc., where he continues to develop and refine his innovative ideas. His work focuses on advancing therapeutic methods that leverage the body's immune response to combat skin diseases effectively. With 1 patent to his name, he is recognized for his contributions to the field.

Collaborations

Sungman Park collaborates with talented individuals such as Yoon-Won Kim and Min Soo Kim. Together, they work towards enhancing the efficacy of treatments and exploring new avenues in medical research.

Conclusion

Sungman Park's innovative work in the treatment of skin diseases showcases the potential of targeted therapies in modern medicine. His contributions are paving the way for new treatment options that could significantly benefit patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…